<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.0 20040730//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurosci Res</journal-id><journal-title>Journal of neuroscience research</journal-title><issn pub-type="ppub">0360-4012</issn><issn pub-type="epub">1097-4547</issn></journal-meta><article-meta><article-id pub-id-type="pmid">17149751</article-id><article-id pub-id-type="doi">10.1002/jnr.21139</article-id><article-id pub-id-type="manuscript">ukpmcpa543</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mouse and rat BDNF gene structure and expression revisited</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aid</surname><given-names>Tamara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kazantseva</surname><given-names>Anna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Piirsoo</surname><given-names>Marko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Palm</surname><given-names>Kaia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Timmusk</surname><given-names>T&#x000f5;nis</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><aff id="A1">Department of Gene Technology, Tallinn University of Technology, Tallinn, Estonia</aff></contrib-group><author-notes><corresp id="CR1"><label>*</label>Correspondence to T&#x000f5;nis Timmusk, Department of Gene Technology, Tallinn University of Technology, Akadeemia tee 15, 19086 Tallinn, Estonia; e-mail: <email>tonis.timmusk@ttu.ee</email>; Tel: +372 620 4445; Fax: +372 620 4401</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>5</month><year>2007</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>2</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>5</month><year>2007</year></pub-date><volume>85</volume><issue>3</issue><fpage>525</fpage><lpage>535</lpage><abstract><p id="P2">Brain-derived neurotrophic factor (BDNF) has important functions in the development of the nervous system and in brain plasticity-related processes such as memory, learning and drug addiction. Despite the fact that the function and regulation of rodent BDNF gene expression has received close attention during the last decade, knowledge of the structural organization of mouse and rat BDNF gene has remained incomplete. We have identified and characterized several mouse and rat BDNF transcripts containing novel 5&#x02019; untranslated exons and introduced a new numbering system for mouse and rat BDNF exons. According to our results both, mouse and rat BDNF gene consist of eight 5&#x02032; untranslated exons and one protein coding 3&#x02019; exon. Transcription of the gene results in BDNF transcripts containing one of the eight 5&#x02032; exons spliced to the protein coding exon and in a transcript containing only 5&#x02032;-extended protein coding exon. We also report the distinct tissue-specific expression profiles of each of the mouse and rat 5&#x02032; exon-specific transcripts in different brain and non-neural tissues. In addition, we show that kainic acid-induced seizures that lead to changes in cellular Ca<sup>2+</sup> levels as well as inhibition of DNA methylation and histone deacetylation contribute to the differential regulation of the expression of BDNF transcripts. Finally, we confirm that mouse and rat BDNF gene loci do not encode antisense mRNA transcripts suggesting that mechanisms of regulation for rodent and human BDNF genes to differ substantially.</p></abstract><kwd-group><kwd><italic>BDNF</italic></kwd><kwd>exon</kwd><kwd>promoter</kwd><kwd>DNA methylation</kwd><kwd>histone deacetylation</kwd><kwd>calcium</kwd><kwd>kainic acid</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p id="P3">Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, which consists of small secreted proteins that play important roles in the development of the nervous system in vertebrates (for recent reviews see (<xref ref-type="bibr" rid="R4">Bibel and Barde, 2000</xref>; <xref ref-type="bibr" rid="R6">Binder and Scharfman, 2004</xref>; <xref ref-type="bibr" rid="R13">Chao et al., 2006</xref>). BDNF supports the survival and differentiation of specific populations of embryonic neurons <italic>in vivo</italic>, and growing evidence indicates that BDNF is also involved in several functions in adulthood, including neuronal homeostasis and brain plasticity-related processes such as memory, learning (<xref ref-type="bibr" rid="R62">Tyler et al., 2002</xref>; <xref ref-type="bibr" rid="R66">Yamada et al., 2002</xref>) and drug addiction (<xref ref-type="bibr" rid="R8">Bolanos and Nestler, 2004</xref>). Alterations in BDNF expression in specific neuron subpopulations contributes to various pathologies, including depression, epilepsy, Alzheimer&#x02019;s, Huntington and Parkinson&#x02019;s disease (<xref ref-type="bibr" rid="R4">Bibel and Barde, 2000</xref>; <xref ref-type="bibr" rid="R43">Murer et al., 2001</xref>; <xref ref-type="bibr" rid="R6">Binder and Scharfman, 2004</xref>; <xref ref-type="bibr" rid="R10">Castren, 2004</xref>; <xref ref-type="bibr" rid="R11">Cattaneo et al., 2005</xref>; <xref ref-type="bibr" rid="R47">Russo-Neustadt and Chen, 2005</xref>).</p><p id="P4">In addition to BDNF, neurotrophin family includes nerve growth factor, neurotrophin-3 and neurotrophin-4/5 (<xref ref-type="bibr" rid="R5">Binder, 2004</xref>). All neurotrophins bind to p75<sup>NGFR</sup> receptor but selectively interact with their individual high-affinity protein kinase receptors of the <italic>trk</italic> (tropomyosin-related kinase) family (<xref ref-type="bibr" rid="R29">Kaplan and Miller, 2000</xref>; <xref ref-type="bibr" rid="R12">Chao, 2003</xref>; <xref ref-type="bibr" rid="R56">Teng and Hempstead, 2004</xref>). BDNF mediates its biological effects via TrkB and p75<sup>NGFR</sup> receptors. Binding of mature BDNF protein to TrkB and p75<sup>NGFR</sup> promotes cell survival, neurite outgrowth, synaptic transmission, plasticity and cell migration (<xref ref-type="bibr" rid="R19">Dechant and Barde, 2002</xref>). Uncleaved precursor BDNF protein (proBDNF) has altered binding characteristics and distinct biological activity in comparison with mature BDNF protein (<xref ref-type="bibr" rid="R33">Lee et al., 2001</xref>; <xref ref-type="bibr" rid="R55">Teng et al., 2005</xref>).</p><p id="P5">In mouse and rat, BDNF mRNA is expressed throughout development and differentially in adult tissues (<xref ref-type="bibr" rid="R20">Ernfors et al., 1990</xref>; <xref ref-type="bibr" rid="R26">Hofer et al., 1990</xref>; <xref ref-type="bibr" rid="R27">Hohn et al., 1990</xref>). In the brain, BDNF mRNA and protein expression becomes detectable during embryonic development, reaching the highest levels by days 10 to 14 postnatally and decreasing thereafter. In the adult animal BDNF is expressed throughout the brain, with the highest levels in the neurons of hippocampus (<xref ref-type="bibr" rid="R20">Ernfors et al., 1990</xref>; <xref ref-type="bibr" rid="R26">Hofer et al., 1990</xref>; <xref ref-type="bibr" rid="R30">Kawamoto et al., 1996</xref>; <xref ref-type="bibr" rid="R17">Conner et al., 1997</xref>; <xref ref-type="bibr" rid="R67">Yan et al., 1997</xref>). Neuronal BDNF expression is affected by many stimuli, such as GABAergic and glutamatergic neurotransmission and membrane depolarization through calcium-mediated pathway (<xref ref-type="bibr" rid="R69">Zafra et al., 1990</xref>; <xref ref-type="bibr" rid="R68">Zafra et al., 1991</xref>; <xref ref-type="bibr" rid="R22">Ghosh et al., 1994</xref>; <xref ref-type="bibr" rid="R50">Shieh and Ghosh, 1999</xref>; <xref ref-type="bibr" rid="R63">West et al., 2001</xref>;). BDNF gene expression is controlled by multiple activity-dependent and tissue-specific promoters. Four BDNF promoters have been previously identified in rat (<xref ref-type="bibr" rid="R40">Metsis et al., 1993</xref>; <xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>; <xref ref-type="bibr" rid="R58">Timmusk et al., 1995</xref>) each driving the transcription of BDNF mRNAs containing one of the four 5&#x02019; non-coding exons (I, II, III or IV) spliced to the common 3&#x02019; coding exon. Several transcription factors contributing to the regulation of BDNF promoters have been characterized. Among these factors are cAMP-responsive element binding protein (CREB) (<xref ref-type="bibr" rid="R51">Shieh et al., 1998</xref>; <xref ref-type="bibr" rid="R53">Tao et al., 1998</xref>; <xref ref-type="bibr" rid="R52">Tabuchi et al., 2002</xref>;) and upstream stimulatory factors 1/2 (USF1/2) (<xref ref-type="bibr" rid="R52">Tabuchi et al., 2002</xref>; <xref ref-type="bibr" rid="R15">Chen et al., 2003b</xref>), which regulate BDNF promoters I and III. In addition, calcium-responsive transcription factor (CaRF) has been found to mediate BDNF transcription through binding to BDNF promoter III upon neuronal activation (<xref ref-type="bibr" rid="R54">Tao et al., 2002</xref>). Chromatin remodeling by DNA methylation and histone deacetylation also plays an important role in cell-specific and activity-dependent regulation of BDNF gene by recruiting global repressors such as REST/NRSF to promoter II (<xref ref-type="bibr" rid="R44">Palm et al., 1998</xref>; <xref ref-type="bibr" rid="R59">Timmusk et al., 1999</xref>; <xref ref-type="bibr" rid="R71">Zuccato et al., 2003</xref>) and MeCP2 to promoter III (<xref ref-type="bibr" rid="R14">Chen et al., 2003a</xref>; <xref ref-type="bibr" rid="R38">Martinowich et al., 2003</xref>).</p><p id="P6">Unraveling the regulation of BDNF gene expression is important for understanding its contribution to nervous system function and pathology. Provided that BDNF actions are most frequently modeled in rodents, detailed knowledge of the structural organization of rodent BDNF genes would be imperative. We undertook this study to specify the structure and expression of BDNF gene in mouse and rat. We show that rodent BDNF gene structure and expression is more complex than initially characterized (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>) and that novel, yet unidentified regulatory sequences may contribute to cell-specific and activity-dependent regulation of rodent BDNF expression.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and methods</title><sec id="S3"><title>DNA and amino acid sequence analysis</title><p id="P7">Mouse and rat BDNF gene structure <italic>in silico</italic> analysis was performed using genomic, mRNA and EST databases (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>). Alignment tools available at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link> as well as software provided by BIIT group at University of Tartu, Estonia, were used for homology searches and analysis. AntiHunter software (available at <ext-link ext-link-type="uri" xlink:href="http://bio.ifom-firc.it/ANTIHUNTER/">http://bio.ifom-firc.it/ANTIHUNTER/</ext-link>) was used to search for opposite strand transcripts in mouse and rat BDNF genomic region.</p></sec><sec id="S4"><title>RNA isolation, cDNA synthesis, RT-PCR</title><p id="P8">Total RNA from developing and adult mouse and rat total brain and brain regions and nonneural tissues was purified by RNAwiz (Ambion, USA) as recommended by the manufacturer. DNase treatment of total RNA was perfomed using TURBO DNA-<italic>free</italic> Kit (Ambion, USA) according to manufacturer&#x02019;s instructions. Five micrograms of total RNA from different tissues was used for first-strand synthesis using oligo(dT) and SuperScript III First-Strand synthesis system (Invitrogen, USA). To analyze expression of BDNF transcripts, reverse primer specific for 3&#x02019; BDNF coding exon and forward primers specific for 5&#x02019; non-coding exons were used. To identify homologues of human antisense BDNF exons in mouse and rat, respective primers were designed corresponding to mouse and rat BDNF genomic regions that showed significant homology with human exons. Total RNA was normalized to the expression of ubiquitously expressed HPRT gene. All primers used in the study are listed below, where <italic>m</italic> designates mouse, <italic>r</italic> - rat, <italic>h</italic> - human, <italic>for</italic> - forward, <italic>rev</italic> - reverse, <italic>anti</italic> - antisense and Arabic numbers designate BDNF exons:<list list-type="simple" id="L1"><list-item><p id="P9">mrBDNFI GTGTGACCTGAGCAGTGGGCAAAGGA</p></list-item><list-item><p id="P10">mrBDNFII GGAAGTGGAAGAAACCGTCTAGAGCA</p></list-item><list-item><p id="P11">mBDNFIII GCTTTCTATCATCCCTCCCCGAGAGT</p></list-item><list-item><p id="P12">rBDNFIII CCTTTCTATTTTCCCTCCCCGAGAGT</p></list-item><list-item><p id="P13">mrBDNFIV CTCTGCCTAGATCAAATGGAGCTTC</p></list-item><list-item><p id="P14">mrBDNFV CTCTGTGTAGTTTCATTGTGTGTTC</p></list-item><list-item><p id="P15">mBDNFVI GCTGGCTGTCGCACGGTTCCCATT</p></list-item><list-item><p id="P16">rBDNFVI GCTGGCTGTCGCACGGTCCCCATT</p></list-item><list-item><p id="P17">mrBDNFVII CCTGAAAGGGTCTGCGGAACTCCA</p></list-item><list-item><p id="P18">mrBDNFVIII GTGTGTGTCTCTGCGCCTCAGTGGA</p></list-item><list-item><p id="P19">mBDNFIXA CCCAAAGCTGCTAAAGCGGGAGGAAG</p></list-item><list-item><p id="P20">rBDNFIXA CCAGAGCTGCTAAAGTGGGAGGAAG</p></list-item><list-item><p id="P21">hmrHPRTfor GATGATGAACCAGGTTATGAC</p></list-item><list-item><p id="P22">hmrHPRTrev GTCCTTTTCACCAGCAAGCTTG</p></list-item><list-item><p id="P23">mrBDNFrev GAAGTGTACAAGTCCGCGTCCTTA</p></list-item></list></p><p id="P24">To analyze expression of mouse and rat exon I-IV, VI- and exon IXA-specific transcripts, cDNA was amplified in a total volume of 25 &#x003bc;l with 35 cycles of PCR using HotFire polymerase system (Solis BioDyne, Estonia). Annealing temperature of 60&#x000b0;C was used for all primer combinations. Due to relatively low expression levels of BNDF mRNAs containing exons V, VII, and VIII, a more robust HotStartTaq Master Mix kit (Qiagen, USA) was used for cDNA amplification for 40-45 PCR cycles. All RT-PCR reactions were performed in triplicates. PCR products were resolved in 1.2% agarose gel and visualized by staining with ethidium bromide. PCR fragments were subsequently excised from the gel, cloned by using pCRII-TOPO cloning system (Invitrogen, USA) and subjected to sequence analysis.</p></sec><sec id="S5"><title>5&#x02019; RACE analyses of transcription initiation sites</title><p id="P25">To determine the transcription start sites of novel BDNF transcripts, 5&#x02019; rapid amplification of cDNA ends (RACE) was performed by using the GeneRacer kit (Invitrogen, USA) according to the manufacturer&#x02019;s instructions. PCR amplification was performed using HotStartTaq Master Mix kit (Qiagen), GeneRacer 5&#x02019; forward primer and reverse primers specific for exons III, V, VII, VIII and IXA. Then, nested PCR was performed to increase the specificity and sensitivity of RACE using GeneRacer 5&#x02019; nested primer and nested primers specific for exons III, V, VII, VIII and IXA. RACE products were analyzed in a 2% gel and cloned into the pCRII-Topo vector (Invitrogen, USA) for sequence analysis. Primers used for RACE analysis are listed below:<list list-type="simple" id="L2"><list-item><p id="P26">rBDNFIIIRACE TCAATGAAGCATCCAGCCCGGCA</p></list-item><list-item><p id="P27">rBDNFIIINested CGGAACTCTCGGGGAGGGAAAATA</p></list-item><list-item><p id="P28">rBDNFVRACE GAACACACAATGAAACTACACAGAG</p></list-item><list-item><p id="P29">rBDNFVIIRACE CTAAAGAGGTGCGCTGGATGGACAGAG</p></list-item><list-item><p id="P30">rBDNFVIINested GGACCTGGAGTTCCGCAGACCCTTT</p></list-item><list-item><p id="P31">rBDNFVIIIRACE CCATTTTCAGCAATCGTTTGTTCAGC</p></list-item><list-item><p id="P32">rBDNFVIIINested GAGACACACACCACAGCCTTTCTC</p></list-item><list-item><p id="P33">rBDNFIXARACE GAGTAAACGGTTTCTAAGCAAGTG</p></list-item><list-item><p id="P34">rBDNFIXANested CTTCCTCCCACTTTAGCAGCTCTG</p></list-item></list></p></sec><sec id="S6"><title>Cell culture and animal experiments</title><p id="P35">Rat glioma C6 and mouse neuroblastoma Neuro2A cells were plated 16 hrs before treatment in DMEM (Invitrogen, USA) containing 10% FBS, 100 units/ml penicillin, 100 &#x003bc;g/ml streptomycin). Trichostatin A (TSA) and 5-Aza-2&#x02019;-deoxycytidine (5AzadC) were purchased from Sigma-Aldrich. Neuro-2A and C6 cells were treated for 48 hours with 5AzadC (1 &#x003bc;M) or with TSA (333 nM) to analyze the effects of 5AzadC and TSA on the expression of BDNF.</p><p id="P36">Adult male Sprague-Dawley rats were injected with glutamate analog kainic acid as previously described (<xref ref-type="bibr" rid="R40">Metsis et al., 1993</xref>). Animals were sacrificed 1, 3, 6, 12 and 24 hours post-treatment. Total RNA from hippocampi was extracted using RNAwiz&#x02122; RNA Isolation Reagent (Ambion) according to the manufacturer&#x02019;s recommendations. All animal experiments were performed according to the norms of the local Ethical Committee of Animal Experimentation.</p></sec></sec><sec sec-type="results" id="S7"><title>Results</title><sec id="S8"><title>New nomenclature for mouse and rat BDNF gene</title><p id="P37">BDNF gene is transcribed from multiple promoters located upstream of distinct 5&#x02019; non-coding exons to produce a heterogeneous population of BDNF mRNAs. Although this conserved feature of BDNF has been described in several species, including human (<xref ref-type="bibr" rid="R36">Liu et al., 2005</xref>), mouse (<xref ref-type="bibr" rid="R24">Hayes et al., 1997</xref>), rat (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>) and zebrafish (<xref ref-type="bibr" rid="R25">Heinrich and Pagtakhan, 2004</xref>), detailed analyses of rodent BDNF gene structure has not been performed. In rat, four 5&#x02019; non-coding exons (I-IV) which are spliced to the common 3&#x02019; coding exon (<xref ref-type="fig" rid="F1">Fig. 1A</xref>) have previously been identified (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>). In mouse, only homologues of rat BDNF exons I and II have been reported (<xref ref-type="bibr" rid="R24">Hayes et al., 1997</xref>). <italic>In silico</italic> analysis of mouse and rat BDNF gene structure performed in the present study showed that BDNF exons III and IV are present and expressed in mouse as well. Moreover, a number of EST and mRNA sequences aligned to the locations of potential novel BDNF exons and the respective sequences turned out to be highly conserved in rat and mouse genome. Furthermore, analysis of BDNF 5&#x02019; RACE products from human hippocampal RNA revealed still additional novel exons (Kazantseva et al., unpublished) the sequences of which were also conserved in mouse and rat genomes. Identification of rodent BDNF transcripts containing novel exons by RT-PCR and subsequent cloning and sequencing confirmed the bioinformatic analyses data. Altogether our results show that both rat and mouse BDNF gene contains eight 5&#x02019; non-coding exons and one 3&#x02032; protein coding exon. All exon-intron junctions display conventional splice-donor and -acceptor sites. A new nomenclature was assigned to mouse and rat BDNF exons (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). In both mouse and rat genomes, the locations of novel BDNF exons are as following: exon III (corresponding to rat exon Ia described by <xref ref-type="bibr" rid="R7">Bishop et al., 1994</xref>) is located 0.6 kb downstream of previously described exon II, exon V sites 0.25 kb downstream of exon IV (exon IV is the former exon III according to <xref ref-type="bibr" rid="R57">Timmusk et al. 1993</xref>), exon VII is located 0.6 kb downstream of exon VI (exon VI corresponds to exon IV in <xref ref-type="bibr" rid="R57">Timmusk et al. 1993</xref>), exon VIII is 13.5 kb upstream of the protein coding exon and exon IXA is a 5&#x02032; extended variant of the protein coding exon (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Homology of human and rodent BDNF 5&#x02019; exons is ranging from 95% to 45%, reaching 95% for exon I, 93% for exon II, 62% for exon III, 91% for exon IV, 86% for exon VI (corresponds to exon V in human according to <xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>) and 45% for exon VII (corresponds to exon VIA in human according to <xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>). All exons that have been defined in human (<xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>) are expressed also in mouse and rat, except for human exons VIIB and VIII. Rodent exons V, VIII and IXA have not been previously described in human (<xref ref-type="bibr" rid="R36">Liu et al., 2005</xref>) but according to our data these exons are expressed in human as well (Kazantseva et al., unpublished). Rat BDNF gene has been suggested to undergo cryptic splicing within exon II (<xref ref-type="bibr" rid="R58">Timmusk et al., 1995</xref>). In agreement with the recently updated version of GenBank&#x02019;s submission (AY057907) our results show that usage of alternative splice donor sites (A, B and C in <xref ref-type="fig" rid="F1">Fig. 1B</xref>) within BDNF exon II leads to three different exon II transcript variants in both in mouse and rat.</p><sec id="S9"><title>Expression analysis of mouse and rat BDNF transcripts</title><p id="P38">Rat BDNF transcripts containing exons I, II, IV (former III) and VI (former IV) and their tissue-specific expression profiles have previously been described (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>), whereas there are no data on the expression of the novel rat BDNF exons V, VII, VIII and IXA, and only limited data are available about the expression patterns of rat exon III (<xref ref-type="bibr" rid="R7">Bishop et al., 1994</xref>). Furthermore, although promoter regions upstream of mouse BDNF exons I and II have been described (<xref ref-type="bibr" rid="R24">Hayes et al., 1997</xref>), no data are available for the expression of mouse BDNF transcripts containing exons I - IXA. In the present work, RT-PCR analysis of the expression profiles of all BDNF transcripts was carried out in developing and adult brain as well as in peripheral tissues of mouse and rat (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p><p id="P39">Expression of rat exon I BDNF mRNA, which was previously described as a brain-specific transcript (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>), was also observed at low levels in several non-neural tissues, including testis, lung, thymus, liver and spleen (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Expression of mouse exon I transcripts was detected in addition to brain only in thymus (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). In adult mouse and rat brain, BDNF exon I mRNAs were expressed in all regions studied, with the lowest levels in cerebellum. In developing mouse and rat brain, low levels of BDNF exon I transcripts were expressed at embryonic (E) day 13 and 15, the expression levels peaked at postnatal (P) day 1 in mouse and embryonic day 21 in rat and decreased slightly during postnatal development (<xref ref-type="fig" rid="F2">Fig. 2A,B</xref>). BDNF exon II mRNA splice variants A, B and C revealed differential expression patterns in brain both in mouse and rat and their expression was not detected in peripheral tissues. In cerebellum exon IIA transcript was the most abundant while in hippocampus all three exon II splice variants were expressed at similar levels. Overall brain-specific expression pattern of mouse and rat novel BDNF exon III transcripts resembled that of BDNF exon II (<xref ref-type="fig" rid="F2">Fig. 2A, B</xref>). In murine non-neural tissues low levels of exon III transcripts were detected only in spleen and kidney, and in rat exon III transcripts were detected in thymus. BDNF exon IV and exon VI mRNAs (formerly exons III and IV, <xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>) were observed at significant levels in developing mouse and rat brain already at E13, the earliest developmental stage studied. Both in mouse and rat, BDNF exon IV and exon VI mRNA levels increased gradually during embryonic and postnatal development and decreased slightly in adult brain. In adult brain, exon IV and exon VI transcripts were detected in all analyzed brain regions both in mouse and rat. Exon IV and exon VI transcripts exhibited wide patterns of expression in mouse and rat non-neural tissues with the highest levels in heart and lung (<xref ref-type="fig" rid="F2">Fig. 2A, B</xref>).</p><p id="P40">In both mouse and rat, BDNF novel exons V, VII and VIII, were expressed at relatively low levels during brain development, broadly in adult peripheral tissues and differentially in adult brain regions (<xref ref-type="fig" rid="F2">Fig. 2A, B</xref>). In spite of the fact that mouse BDNF mRNA containing exons VII and VIII in the same transcript has been submitted to NCBI GenBank (AY231132), we failed to detect similar mRNAs in any of mouse or rat tissue studied.</p><p id="P41">Expression of the novel BDNF exon IXA transcripts was detected in rodent brain during embryonic development as well as in adulthood. In mouse adult brain exon IXA-containing transcripts were expressed at similar levels in all brain regions (<xref ref-type="fig" rid="F2">Fig. 2A</xref>), whereas in rat adult brain exon IXA expression was detected at high levels in hippocampus, olfactory bulb, colliculus and cerebellum and at lower levels in cortex and pons (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). In rodent non-neural tissues relatively high levels of exon IXA transcripts were observed in heart and lung.</p></sec></sec><sec id="S10"><title>Identification of the transcription start sites for BDNF new exons III, V, VII and VIII in rat</title><p id="P42">The transcription initiation sites for rat BDNF exons I, II, IV and VI have been determined earlier (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>). To identify the transcription start sites for novel BDNF transcripts, 5&#x02019; rapid amplification of cDNA ends (5&#x02019; RACE) from rat hippocampal RNA was performed by using antisense primers specific for exons III, V, VII, VIII and IXA. Sequencing analysis of different RACE clones showed that major transcription initiation sites are located at 152 bp and 230 bp for exon III, at 81 bp for exon V, at 277 bp and 286 bp for exon VIII upstream of the 3&#x02019; end of the respective exon, and at 476 bp and 363 bp for exon IXA upstream of the major splice site of this exon (<xref ref-type="fig" rid="F3">Fig. 3</xref>). None of the identified 5&#x02019; exons contains upstream open reading frames, thus the usage of these 5&#x02019;UTRs will apparently not affect amino acid composition of the protein product. Due to very low expression levels, we failed to map the transcription start site for rodent BDNF exon VII. However, 5&#x02019; RACE analysis of rodent exon VII homologue in human showed that transcription initiation site for this exon is located at 285 bp upstream of its 3&#x02019; end (Kazantseva et al. unpublished). These data strongly suggest that, similarly to BDNF exon I, II, IV and VI mRNAs (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>), novel exon III, V, VII, VIII and IXA mRNAs are also transcribed from separate promoters.</p></sec><sec id="S11"><title>Differential regulation of BDNF expression by DNA methylation and histone deacetylation</title><p id="P43">Provided that methylation of the cytosine residues in the CpG dinucleotides in genome and posttranslational modifications of histones in the nucleosome establish epigenetic codes for gene regulation in different tissues, including nervous system (<xref ref-type="bibr" rid="R28">Hsieh and Gage, 2004</xref>; <xref ref-type="bibr" rid="R2">Ballas and Mandel, 2005</xref>), we investigated the potential role of chromatin structure on transcriptional activity of BDNF promoters. By treating rat C6 glioma cells and mouse Neuro2A neuroblastoma cells with the DNA methyltransferase inhibitor 5-Aza-2&#x02019;-deoxycytidine (5AzadC) or with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) for 48 hours we examined the role of DNA methylation and histone acetylation respectively in the regulation of BDNF gene expression.</p><p id="P44">We observed robust activation of the expression of BDNF exon I and IV as well as novel exon V, VIII and IXA transcripts in rat C6 glioma cells following 5AzadC treatment (<xref ref-type="fig" rid="F4">Fig. 4</xref>). Expression of exons III and VI in C6 cells was moderately induced by inhibition of DNA methylation. Expression of BDNF exon I and exon III transcripts in Neuro2A cells was significantly induced following 5AzadC treatment, whereas there was no change in the levels of other BDNF mRNAs (<xref ref-type="fig" rid="F4">Fig. 4</xref>). In Neuro2A cells, TSA treatment failed to relieve repression of any of the BDNF promoters. However, in C6 cells inhibition of histone deacetylation by TSA increased the levels of BDNF exon III, exon VII and exon IXA transcripts. Muscarinic acetylcholine receptor gene M4 was used as a reference because its expression has been shown to be regulated by 5AzadC in various cell lines, other than C6 and Neuro2A, in a cell type-specific manner (<xref ref-type="bibr" rid="R37">Lunyak et al., 2002</xref>; <xref ref-type="bibr" rid="R65">Wood et al., 2003</xref>). Our findings suggest that DNA methylation and histone deacetylation could play a role in silencing of BDNF gene in a promoter- and cell-specific manner both in C6 and Neuro2A cells.</p></sec><sec id="S12"><title>Activity-dependent regulation of rat BDNF exon-specific mRNAs in the hippocampus by kainic acid-induced seizures</title><p id="P45">Glutamate analogue kainic acid induces rise in intracellular Ca<sup>2+</sup> levels and differential activation of four previously characterized BDNF promoters in the hippocampus and cerebral cortex of adult rat brain (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>). We examined whether expression of the BDNF mRNAs containing novel 5&#x02019; exons is regulated by kainic acid 1, 3, 6, 12 and 24 hours after drug administration. The results revealed differential regulation patterns for BDNF transcripts. BDNF exon I and IV transcripts (exons I and III according to <xref ref-type="bibr" rid="R57">Timmusk et al. 1993</xref>) have previously been characterized as the most highly induced BDNF mRNAs in response to kainic acid treatment. It was remarkable that in our experiments not only these BDNF transcripts were induced by kainate, but also the levels of novel exon V, VII, VIII and IXA mRNAs were upregulated peaking at 3 to 6 hours post-treatment and rapidly down-regulated to basal levels thereafter (<xref ref-type="fig" rid="F5">Fig. 5</xref>). The levels of exon IV transcripts remained elevated at 3 - 24 hours post-treatment. BDNF transcripts with exon IIA, IIB and IIC exhibited differential expression profiles in response to kainite treatment. The levels of exon IIC transcripts were markedly elevated at 3 hours, peaked at 6 hours, and decreased at 12-24 hours after kainate treatment. Expression levels of exon 2A and exon 2B transcripts increased moderately at 3 hours, dropped at 6 hours and reached the basal levels at 24 hours post-treatment (<xref ref-type="fig" rid="F5">Fig. 5</xref>). In contrast, the expression levels of BDNF exon III and exon VI mRNAs did not change at any time point studied (<xref ref-type="fig" rid="F5">Fig. 5</xref>). These results agree with the previous reports on the transcript-specific regulation of rat BDNF mRNAs in response to kainate-induced seizures (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>; <xref ref-type="bibr" rid="R48">Sathanoori et al., 2004</xref>;) and provide the first evidence that the novel BDNF mRNAs are differentially regulated by kainic acid. Our data strongly suggest that yet unexplored regulatory elements within BDNF gene contribute to the activity-dependent regulation of BDNF mRNA expression.</p></sec><sec id="S13"><title>Antisense-BDNF transcripts are not expressed in mouse and rat</title><p id="P46">It was shown recently (<xref ref-type="bibr" rid="R36">Liu et al., 2005</xref>) that protein non-coding antisense transcripts are expressed from human BDNF gene locus. Analyses of mouse and rat BDNF gene loci with AntiHunter software tool (<xref ref-type="bibr" rid="R32">Lavorgna et al., 2004</xref>) did not reveal any BDNF antisense transcripts from EST databases. Moreover, alignment of human antisense BDNF exons sequences with mouse and rat EST databases at NCBI did not reveal any rodent ESTs homologous to human antisense BDNF transcripts. Failure to find antisense ESTs transcribed from mouse and rat BDNF gene loci could be explained by the fact that although EST databases are growing rapidly, they are still under-sampling the full mammalian transcriptome. Therefore we aligned the sequences of human antisense BDNF exons with the respective regions of mouse and rat BDNF genomic sequence. Interestingly, sequences with significant homology to human antisense exons, although present in chimpanzee genome, were missing from mouse and rat genomes. RT-PCR analysis with mouse- and rat-specific primers annealing to the very short regions of homology with human antisense transcripts failed to detect expression of antisense BDNF transcripts in mouse and rat tissues. Therefore, we concluded that antisense BDNF transcripts are human- or primate-specific as proposed earlier by Liu and colleagues (<xref ref-type="bibr" rid="R36">Liu et al., 2005</xref>).</p></sec></sec><sec sec-type="discussion" id="S14"><title>Discussion</title><p id="P47">Since the purification of BDNF protein definitive evidence has emerged for its central role in mammalian brain development, physiology and pathology. However, the structural organization of rodent BDNF gene has not been revisited since four 5&#x02019; exons were first discovered and nomenclature of exons established for rat BDNF gene (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>). This numeration of BDNF exons is currently widely used by scientific community. In the present work we show, however, that mouse and rat BDNF gene structure is much more complex than was accepted before. According to our data, mouse and rat BDNF gene consist of a common 3&#x02032;-exon that encodes the proBDNF protein and at least eight 5&#x02019; non-coding exons (exons I - VIII). In each BDNF transcript one 5&#x02019; exon is spliced to the protein coding exon. All 5&#x02019; exons are controlled by distinct promoters as evidenced by our RACE analysis of the 5&#x02019; ends of these exons, as well as expression analysis data. In addition, we identified a novel BDNF transcript both in mouse and rat that contains only exon IXA, the 5&#x02032;-extended protein coding exon. Here we suggest a new numbering system for mouse and rat BDNF exons. Respective to the old nomenclature (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>), former exon III corresponds to exon IV, previous exon IV is now exon VI and coding exon, previously called exon V, is now exon IX.</p><p id="P48">Pro-BDNF, a 32-kDa precursor, undergoes cleavage to release mature 14-kDa BDNF protein as well as a minor truncated form of the precursor (28 kDa). Secreted pro-BDNF activates a heteromeric receptor complex of p75 and sortilin to initiate cell death (<xref ref-type="bibr" rid="R55">Teng et al., 2005</xref>) and binds to p75 in hippocampal neurons to enhance long-term depression (<xref ref-type="bibr" rid="R64">Woo et al., 2005</xref>). Studies suggest that pro-neurotrophins account for a significant amount of the total neurotrophins secreted extracellularly, particularly in CNS neurons (<xref ref-type="bibr" rid="R21">Farhadi et al., 2000</xref>; <xref ref-type="bibr" rid="R42">Mowla et al., 2001</xref>). In mouse, rat and human, exon I transcripts contain an in-frame AUG that can serve as an alternative translation initiation codon, extending the prepro-region of BDNF by eight amino acids (<xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>). It can be hypothesized that additional amino acids in the N-terminus of preproBDNF can affect the intracellular trafficking of BDNF and play a role in proBDNF secretion. In human, BDNF 5&#x02019; exons VIB and VII (according to <xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>), can contribute to alternative BDNF protein isoforms, since exon VIB can add fifteen amino acids to the N-terminus of preproBDNF and exon VII can undergo alternative inframe splicing leading to the mature BDNF protein isoform that lacks 48 amino acids internally (<xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>). None of the novel rodent BDNF exons includes an in-frame ATG, predicting that for these transcripts translation is initiated from the BDNF coding exon.</p><p id="P49">BDNF is the most abundant and widely distributed neurotrophin in the mammalian CNS. In addition to refining expression patterns of BDNF transcripts which have been identified earlier, results of this study also show that mouse and rat BDNF novel exons III, V, VII, VIII and IXA are differentially expressed in adult brain and in peripheral tissues. In general, exons that are closely located in the genome are expressed in a similar manner: exons I, II and III have brain-enriched expression patterns and exons IV, V and VI are widely expressed also in non-neural tissues. However, 5&#x02018; RACE analysis of transcription initiation sites of rat and mouse BDNF new exons and <italic>in silico</italic> analysis of the regions upstream of these exons (data not shown) suggest that their expression is driven by distinct novel tissue-specific and development- and activity regulated promoters.</p><p id="P50">It has been established earlier by using different cellular and animal models that BDNF gene is regulated by neural activity through calcium-mediated pathways (<xref ref-type="bibr" rid="R50">Shieh and Ghosh, 1999</xref>; <xref ref-type="bibr" rid="R63">West et al., 2001</xref>; <xref ref-type="bibr" rid="R39">Mellstrom et al., 2004</xref>) and that BDNF transcripts containing exons I, II and IV are differentially regulated. BDNF exon I and exon IV transcripts (exons I and III according to <xref ref-type="bibr" rid="R57">Timmusk et al. 1993</xref>) have previously been characterized as the most highly induced BDNF mRNAs in response to kainate treatment and KCl-mediated membrane depolarization in embryonic cortical neuron cultures (<xref ref-type="bibr" rid="R53">Tao et al., 1998</xref>). Several calcium responsive elements and transcription factors binding to these elements have been characterized in the promoter regions upstream of these exons (<xref ref-type="bibr" rid="R59">Timmusk et al., 1999</xref>; <xref ref-type="bibr" rid="R52">Tabuchi et al., 2002</xref>; <xref ref-type="bibr" rid="R54">Tao et al., 2002</xref>; <xref ref-type="bibr" rid="R15">Chen et al., 2003b</xref>). Here we show that BDNF exon V, exon VII, exon VIII and exon IXA transcripts are also regulated by kainic acid and that the induction magnitude is comparable to that of BDNF exon I and IV transcripts. In the light of our findings, it is attractive to speculate that differential regulation of nine BDNF exon mRNAs would become apparent in different neurodegenerative diseases, where BDNF levels are altered (<xref ref-type="bibr" rid="R46">Phillips et al., 1991</xref>; <xref ref-type="bibr" rid="R41">Mogi et al., 1999</xref>; <xref ref-type="bibr" rid="R45">Parain et al., 1999</xref>; <xref ref-type="bibr" rid="R70">Zuccato et al., 2001</xref>). Also, differential regulation of BDNF mRNAs can take place for example in depression, stress, exercise, and learning (<xref ref-type="bibr" rid="R18">Cotman and Berchtold, 2002</xref>; <xref ref-type="bibr" rid="R62">Tyler et al., 2002</xref>; <xref ref-type="bibr" rid="R23">Hashimoto et al., 2004</xref>; <xref ref-type="bibr" rid="R47">Russo-Neustadt and Chen, 2005</xref>). Future characterization of the regulatory sequences and transcription factors mediating regulation of novel BDNF transcripts in different disease models is important for understanding of BDNF gene regulation and its contribution to pathology.</p><p id="P51">The role of chromatin remodeling in the activity of different BDNF promoters has been investigated by several recent studies. Neuronal activity-dependent activation of BDNF gene is mediated by decreased CpG methylation of <italic>BDNF</italic> promoter IV and release of a repressor complex containing methyl-cytosine binding protein MeCP2, histone deacetylases HDAC1 and HDAC2, and co-repressor mSin3A (<xref ref-type="bibr" rid="R14">Chen et al., 2003a</xref>; <xref ref-type="bibr" rid="R38">Martinowich et al., 2003</xref>). It has also been shown that histone modifications at specific BDNF promoters are involved in chromatin remodeling during electroconvulsive seizures (<xref ref-type="bibr" rid="R61">Tsankova et al., 2004</xref>) and cocaine-induced plasticity (<xref ref-type="bibr" rid="R31">Kumar et al., 2005</xref>) in rat, and in a mouse model of depression and antidepressant treatment (<xref ref-type="bibr" rid="R60">Tsankova et al., 2006</xref>). In addition, zinc finger transcription factor REST/NRSF (<xref ref-type="bibr" rid="R16">Chong et al., 1995</xref>; <xref ref-type="bibr" rid="R49">Schoenherr and Anderson, 1995</xref>), that recruits multiple co-factors including HDAC1, HDAC2 and mSin3A (reviewed in (<xref ref-type="bibr" rid="R2">Ballas and Mandel, 2005</xref>) to repress its target genes, negatively regulates BDNF gene expression by binding to NRSE/RE1 element in BDNF promoter II (<xref ref-type="bibr" rid="R44">Palm et al., 1998</xref>; <xref ref-type="bibr" rid="R59">Timmusk et al., 1999</xref>; <xref ref-type="bibr" rid="R9">Bruce et al., 2004</xref>; <xref ref-type="bibr" rid="R1">Ballas et al., 2005</xref>). The present study showed that DNA demethylating agent 5AzadC evoked robust activation of the BDNF gene expression in C6 rat glioma cells and more moderate activation in Neuro2A mouse neuroblastoma cells in a transcript-specific manner: induction of exon I, III, IV, V, VIII and exon IXA mRNAs was observed in C6 cells whereas only exon I and exon III mRNA levels increased in Neuro2A cells. Furthermore, in C6 cells inhibition of histone deacetylation by TSA upregulated the levels of BDNF exon III, exon VII and exon IX transcripts. The results presented in this study suggest the contribution of histone modifications and methylation of BDNF promoters to the regulation of BDNF gene transcription and open up possibilities to address these phenomena in more detail.</p><p id="P52">Last but not the least, we report that in contrast with human BDNF gene locus (<xref ref-type="bibr" rid="R36">Liu et al. 2005</xref>), mouse and rat BDNF gene loci do not encode antisense mRNA transcripts. These findings demonstrate that regulation of BDNF gene expression by antisense-BDNF transcripts clearly is a human- or primate-specific phenomenon and suggest that regulation of rodent and human BDNF gene differs substantially. Human-specific antisense transcripts have been reported for tumor suppressor gene ret finger protein 2 (RFP2) (<xref ref-type="bibr" rid="R3">Baranova et al., 2003</xref>) and for human protocadherin (PCDH) locus (<xref ref-type="bibr" rid="R34">Lipovich et al., 2006</xref>). Since BDNF has important roles in development, particularly of the nervous system, and plays a central role in brain plasticity-related processes, this underscores the possible role for antisense BDNF gene in the regulation of BDNF expression across primates manifesting in specific behavioral phenotypes.</p><p id="P53">During the preparation of this manuscript, an article by Liu and colleagues examining the gene structure and expression of BDNF in rodents was published (<xref ref-type="bibr" rid="R35">Liu et al., 2006</xref>). However, our study elaborates the understanding of rodent BDNF gene loci, since we present several novel data that are complementary to the results of Liu and colleagues. (1) We identified an additional 5&#x02018;exon, exon V, that was not been reported by Liu et al. Thus, both mouse and rat BDNF genes consist of at least eight 5&#x02018;exons spliced to the 3&#x02018;coding exon. In addition, we identified a novel BDNF transcript, exon IXA mRNA, consisting of only the 5&#x02019;-extended protein coding exon. (2) We determined the transcription initiation sites for novel exons (III, V, VII, VIII and IXA) showing that these exons are transcribed from distinct promoters; (3) Our data show that exon VIII (exon VII according to Liu et al.) is driven by a separate promoter. Liu and colleagues&#x02018;data argue that transcripts containing exons VII and VIII (exon VI and VII according to Liu et al.) share the same promoter; (4) Our expression analysis data of all BDNF transcripts includes a wider range of tissues and brain structures analyzed both in rat and mouse; (5) Liu et al. studied the regulation of some BDNF transcripts expression in brain upon administration of cocaine. Our data show activity-dependent regulation of rat BDNF mRNAs by kainic acid-induced seizures in rat hippocampus. Moreover, we report differential regulation of the expression of BDNF transcripts by DNA methylation and histone deacetylation.</p><p id="P54">Taken together, results of the present study on mouse and rat BDNF gene structure and tissue-specific expression provide new challenges and opportunities to identify mechanisms regulating the activity of BDNF novel promoters that contribute to the expression levels of BDNF and possibly also to the changes in BDNF expression in neurodegenerative and neuropsychiatric disorders.</p></sec></body><back><ack id="S15"><title>Acknowledgments</title><p>We thank Kaur Jaanson and Epp V&#x000e4;li for technical assistance and Priit Pruunsild for stimulating discussions and advice. This work was supported by grants from Wellcome Trust International Senior Research Fellowship (Grant 067952) and Estonian Ministry of Education and Research (Grant 0222602) to T.T.</p></ack><fn-group><fn fn-type="supported-by" id="FN2"><p id="P55">Funded by: Wellcome Trust International Senior Research Fellowship (Grant 067952) and Estonian Ministry of Education and Research (Grant 0222602).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballas</surname><given-names>N</given-names></name><name><surname>Grunseich</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>DD</given-names></name><name><surname>Speh</surname><given-names>JC</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><article-title>REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">15907476</pub-id></citation></ref><ref id="R2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballas</surname><given-names>N</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><article-title>The many faces of REST oversee epigenetic programming of neuronal genes</article-title><source>Curr Opin Neurobiol</source><year>2005</year><volume>15</volume><fpage>500</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">16150588</pub-id></citation></ref><ref id="R3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baranova</surname><given-names>A</given-names></name><name><surname>Hammarsund</surname><given-names>M</given-names></name><name><surname>Ivanov</surname><given-names>D</given-names></name><name><surname>Skoblov</surname><given-names>M</given-names></name><name><surname>Sangfelt</surname><given-names>O</given-names></name><name><surname>Corcoran</surname><given-names>M</given-names></name><name><surname>Borodina</surname><given-names>T</given-names></name><name><surname>Makeeva</surname><given-names>N</given-names></name><name><surname>Pestova</surname><given-names>A</given-names></name><name><surname>Tyazhelova</surname><given-names>T</given-names></name><etal/></person-group><article-title>Distinct organization of the candidate tumor suppressor gene RFP2 in human and mouse: multiple mRNA isoforms in both species- and human-specific antisense transcript RFP2OS</article-title><source>Gene</source><year>2003</year><volume>321</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">14636997</pub-id></citation></ref><ref id="R4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bibel</surname><given-names>M</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><article-title>Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>2919</fpage><lpage>2937</lpage><pub-id pub-id-type="pmid">11114882</pub-id></citation></ref><ref id="R5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>DK</given-names></name></person-group><article-title>The role of BDNF in epilepsy and other diseases of the mature nervous system</article-title><source>Adv Exp Med Biol</source><year>2004</year><volume>548</volume><fpage>34</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">15250584</pub-id></citation></ref><ref id="R6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>DK</given-names></name><name><surname>Scharfman</surname><given-names>HE</given-names></name></person-group><article-title>Brain-derived neurotrophic factor</article-title><source>Growth Factors</source><year>2004</year><volume>22</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">15518235</pub-id></citation></ref><ref id="R7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>JF</given-names></name><name><surname>Mueller</surname><given-names>GP</given-names></name><name><surname>Mouradian</surname><given-names>MM</given-names></name></person-group><article-title>Alternate 5&#x02032; exons in the rat brain-derived neurotrophic factor gene: differential patterns of expression across brain regions</article-title><source>Brain Res Mol Brain Res</source><year>1994</year><volume>26</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">7854051</pub-id></citation></ref><ref id="R8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolanos</surname><given-names>CA</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>Neurotrophic mechanisms in drug addiction</article-title><source>Neuromolecular Med</source><year>2004</year><volume>5</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15001814</pub-id></citation></ref><ref id="R9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>AW</given-names></name><name><surname>Donaldson</surname><given-names>IJ</given-names></name><name><surname>Wood</surname><given-names>IC</given-names></name><name><surname>Yerbury</surname><given-names>SA</given-names></name><name><surname>Sadowski</surname><given-names>MI</given-names></name><name><surname>Chapman</surname><given-names>M</given-names></name><name><surname>Gottgens</surname><given-names>B</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><article-title>Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>10458</fpage><lpage>10463</lpage><pub-id pub-id-type="pmid">15240883</pub-id></citation></ref><ref id="R10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castren</surname><given-names>E</given-names></name></person-group><article-title>Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection</article-title><source>Mol Neurobiol</source><year>2004</year><volume>29</volume><fpage>289</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">15181240</pub-id></citation></ref><ref id="R11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>E</given-names></name><name><surname>Zuccato</surname><given-names>C</given-names></name><name><surname>Tartari</surname><given-names>M</given-names></name></person-group><article-title>Normal huntingtin function: an alternative approach to Huntington&#x02019;s disease</article-title><source>Nat Rev Neurosci</source><year>2005</year><volume>6</volume><fpage>919</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">16288298</pub-id></citation></ref><ref id="R12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>MV</given-names></name></person-group><article-title>Neurotrophins and their receptors: a convergence point for many signalling pathways</article-title><source>Nat Rev Neurosci</source><year>2003</year><volume>4</volume><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">12671646</pub-id></citation></ref><ref id="R13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>MV</given-names></name><name><surname>Rajagopal</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name></person-group><article-title>Neurotrophin signalling in health and disease</article-title><source>Clin Sci (Lond)</source><year>2006</year><volume>110</volume><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">16411893</pub-id></citation></ref><ref id="R14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WG</given-names></name><name><surname>Chang</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Meissner</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Griffith</surname><given-names>EC</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2</article-title><source>Science</source><year>2003a</year><volume>302</volume><fpage>885</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">14593183</pub-id></citation></ref><ref id="R15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WG</given-names></name><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Corfas</surname><given-names>G</given-names></name><name><surname>Szentirmay</surname><given-names>MN</given-names></name><name><surname>Sawadogo</surname><given-names>M</given-names></name><name><surname>Vinson</surname><given-names>C</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Upstream stimulatory factors are mediators of Ca2+- responsive transcription in neurons</article-title><source>J Neurosci</source><year>2003b</year><volume>23</volume><fpage>2572</fpage><lpage>2581</lpage><pub-id pub-id-type="pmid">12684442</pub-id></citation></ref><ref id="R16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>JA</given-names></name><name><surname>Tapia-Ramirez</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Toledo-Aral</surname><given-names>JJ</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Boutros</surname><given-names>MC</given-names></name><name><surname>Altshuller</surname><given-names>YM</given-names></name><name><surname>Frohman</surname><given-names>MA</given-names></name><name><surname>Kraner</surname><given-names>SD</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><article-title>REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons</article-title><source>Cell</source><year>1995</year><volume>80</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">7697725</pub-id></citation></ref><ref id="R17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conner</surname><given-names>JM</given-names></name><name><surname>Lauterborn</surname><given-names>JC</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name><name><surname>Varon</surname><given-names>S</given-names></name></person-group><article-title>Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport</article-title><source>J Neurosci</source><year>1997</year><volume>17</volume><fpage>295</fpage><lpage>2313</lpage></citation></ref><ref id="R18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cotman</surname><given-names>CW</given-names></name><name><surname>Berchtold</surname><given-names>NC</given-names></name></person-group><article-title>Exercise: a behavioral intervention to enhance brain health and plasticity</article-title><source>Trends Neurosci</source><year>2002</year><volume>25</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">12086747</pub-id></citation></ref><ref id="R19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dechant</surname><given-names>G</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><article-title>The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system</article-title><source>Nat Neurosci</source><year>2002</year><volume>5</volume><fpage>1131</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">12404007</pub-id></citation></ref><ref id="R20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Wetmore</surname><given-names>C</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name><name><surname>Persson</surname><given-names>H</given-names></name></person-group><article-title>Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family</article-title><source>Neuron</source><year>1990</year><volume>5</volume><fpage>511</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">2206535</pub-id></citation></ref><ref id="R21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farhadi</surname><given-names>HF</given-names></name><name><surname>Mowla</surname><given-names>SJ</given-names></name><name><surname>Petrecca</surname><given-names>K</given-names></name><name><surname>Morris</surname><given-names>SJ</given-names></name><name><surname>Seidah</surname><given-names>NG</given-names></name><name><surname>Murphy</surname><given-names>RA</given-names></name></person-group><article-title>Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>4059</fpage><lpage>4068</lpage><pub-id pub-id-type="pmid">10818141</pub-id></citation></ref><ref id="R22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Carnahan</surname><given-names>J</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Requirement for BDNF in activity-dependent survival of cortical neurons</article-title><source>Science</source><year>1994</year><volume>263</volume><fpage>1618</fpage><lpage>1623</lpage><pub-id pub-id-type="pmid">7907431</pub-id></citation></ref><ref id="R23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>E</given-names></name><name><surname>Iyo</surname><given-names>M</given-names></name></person-group><article-title>Critical role of brain-derived neurotrophic factor in mood disorders</article-title><source>Brain Res Brain Res Rev</source><year>2004</year><volume>45</volume><fpage>104</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">15145621</pub-id></citation></ref><ref id="R24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>VY</given-names></name><name><surname>Towner</surname><given-names>MD</given-names></name><name><surname>Isackson</surname><given-names>PJ</given-names></name></person-group><article-title>Organization, sequence and functional analysis of a mouse BDNF promoter</article-title><source>Brain Res Mol Brain Res</source><year>1997</year><volume>45</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">9149093</pub-id></citation></ref><ref id="R25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>G</given-names></name><name><surname>Pagtakhan</surname><given-names>CJ</given-names></name></person-group><article-title>Both 5&#x02032; and 3&#x02032; flanks regulate Zebrafish brain-derived neurotrophic factor gene expression</article-title><source>BMC Neurosci</source><year>2004</year><volume>5</volume><fpage>19</fpage><pub-id pub-id-type="pmid">15153250</pub-id></citation></ref><ref id="R26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>M</given-names></name><name><surname>Pagliusi</surname><given-names>SR</given-names></name><name><surname>Hohn</surname><given-names>A</given-names></name><name><surname>Leibrock</surname><given-names>J</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><article-title>Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family</article-title><source>Nature</source><year>1990</year><volume>344</volume><fpage>339</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">2314473</pub-id></citation></ref><ref id="R27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hohn</surname><given-names>A</given-names></name><name><surname>Leibrock</surname><given-names>J</given-names></name><name><surname>Bailey</surname><given-names>K</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><article-title>Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family</article-title><source>Nature</source><year>1990</year><volume>344</volume><fpage>339</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">2314473</pub-id></citation></ref><ref id="R28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>J</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Epigenetic control of neural stem cell fate</article-title><source>Curr Opin Genet Dev</source><year>2004</year><volume>14</volume><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">15380235</pub-id></citation></ref><ref id="R29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><article-title>Neurotrophin signal transduction in the nervous system</article-title><source>Curr Opin Neurobiol</source><year>2000</year><volume>10</volume><fpage>381</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">10851172</pub-id></citation></ref><ref id="R30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Nakano</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>N</given-names></name><name><surname>Akiguchi</surname><given-names>I</given-names></name></person-group><article-title>Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain</article-title><source>Neuroscience</source><year>1996</year><volume>74</volume><fpage>1209</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">8895887</pub-id></citation></ref><ref id="R31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Renthal</surname><given-names>W</given-names></name><name><surname>Tsankova</surname><given-names>NM</given-names></name><name><surname>Theobald</surname><given-names>DE</given-names></name><name><surname>Truong</surname><given-names>HT</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Laplant</surname><given-names>Q</given-names></name><name><surname>Sasaki</surname><given-names>TS</given-names></name><name><surname>Whistler</surname><given-names>KN</given-names></name><etal/></person-group><article-title>Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum</article-title><source>Neuron</source><year>2005</year><volume>48</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">16242410</pub-id></citation></ref><ref id="R32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lavorgna</surname><given-names>G</given-names></name><name><surname>Dahary</surname><given-names>D</given-names></name><name><surname>Lehner</surname><given-names>B</given-names></name><name><surname>Sorek</surname><given-names>R</given-names></name><name><surname>Sanderson</surname><given-names>CM</given-names></name><name><surname>Casari</surname><given-names>G</given-names></name></person-group><article-title>In search of antisense</article-title><source>Trends Biochem Sci</source><year>2004</year><volume>29</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15102435</pub-id></citation></ref><ref id="R33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Kermani</surname><given-names>P</given-names></name><name><surname>Teng</surname><given-names>KK</given-names></name><name><surname>Hempstead</surname><given-names>BL</given-names></name></person-group><article-title>Regulation of cell survival by secreted proneurotrophins</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>1945</fpage><lpage>1948</lpage><pub-id pub-id-type="pmid">11729324</pub-id></citation></ref><ref id="R34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipovich</surname><given-names>L</given-names></name><name><surname>Vanisri</surname><given-names>RR</given-names></name><name><surname>Kong</surname><given-names>SL</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name></person-group><article-title>Primate-specific endogenous cis-antisense transcription in the human 5q31 protocadherin gene cluster</article-title><source>J Mol Evol</source><year>2006</year><volume>62</volume><fpage>73</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">16341467</pub-id></citation></ref><ref id="R35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>QR</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>XG</given-names></name><name><surname>Gong</surname><given-names>JP</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name><name><surname>Uhl</surname><given-names>GR</given-names></name></person-group><article-title>Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine</article-title><source>Brain Res</source><year>2006</year><volume>1067</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16376315</pub-id></citation></ref><ref id="R36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>QR</given-names></name><name><surname>Walther</surname><given-names>D</given-names></name><name><surname>Drgon</surname><given-names>T</given-names></name><name><surname>Polesskaya</surname><given-names>O</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><name><surname>Strain</surname><given-names>KJ</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>Bower</surname><given-names>JH</given-names></name><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>Uhl</surname><given-names>GR</given-names></name></person-group><article-title>Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson&#x02019;s Disease</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2005</year><volume>134</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">15666411</pub-id></citation></ref><ref id="R37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lunyak</surname><given-names>VV</given-names></name><name><surname>Burgess</surname><given-names>R</given-names></name><name><surname>Prefontaine</surname><given-names>GG</given-names></name><name><surname>Nelson</surname><given-names>C</given-names></name><name><surname>Sze</surname><given-names>SH</given-names></name><name><surname>Chenoweth</surname><given-names>J</given-names></name><name><surname>Schwartz</surname><given-names>P</given-names></name><name><surname>Pevzner</surname><given-names>PA</given-names></name><name><surname>Glass</surname><given-names>C</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group><article-title>Corepressor-dependent silencing of chromosomal regions encoding neuronal genes</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>1747</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">12399542</pub-id></citation></ref><ref id="R38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinowich</surname><given-names>K</given-names></name><name><surname>Hattori</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Fouse</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>YE</given-names></name></person-group><article-title>DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>890</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">14593184</pub-id></citation></ref><ref id="R39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mellstrom</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>B</given-names></name><name><surname>Link</surname><given-names>WA</given-names></name><name><surname>Naranjo</surname><given-names>JR</given-names></name></person-group><article-title>The BDNF gene: exemplifying complexity in Ca2+ -dependent gene expression</article-title><source>Crit Rev Neurobiol</source><year>2004</year><volume>16</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">15581398</pub-id></citation></ref><ref id="R40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metsis</surname><given-names>M</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Persson</surname><given-names>H</given-names></name></person-group><article-title>Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>8802</fpage><lpage>8806</lpage><pub-id pub-id-type="pmid">8415610</pub-id></citation></ref><ref id="R41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mogi</surname><given-names>M</given-names></name><name><surname>Togari</surname><given-names>A</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Komure</surname><given-names>O</given-names></name><name><surname>Kuno</surname><given-names>S</given-names></name><name><surname>Ichinose</surname><given-names>H</given-names></name><name><surname>Nagatsu</surname><given-names>T</given-names></name></person-group><article-title>Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson&#x02019;s disease</article-title><source>Neurosci Lett</source><year>1999</year><volume>270</volume></citation></ref><ref id="R42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mowla</surname><given-names>SJ</given-names></name><name><surname>Farhadi</surname><given-names>HF</given-names></name><name><surname>Pareek</surname><given-names>S</given-names></name><name><surname>Atwal</surname><given-names>JK</given-names></name><name><surname>Morris</surname><given-names>SJ</given-names></name><name><surname>Seidah</surname><given-names>NG</given-names></name><name><surname>Murphy</surname><given-names>RA</given-names></name></person-group><article-title>Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>12660</fpage><lpage>12666</lpage><pub-id pub-id-type="pmid">11152678</pub-id></citation></ref><ref id="R43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murer</surname><given-names>MG</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Raisman-Vozari</surname><given-names>R</given-names></name></person-group><article-title>Brain-derived neurotrophic factor in the control human brain, and in Alzheimer&#x02019;s disease and Parkinson&#x02019;s disease</article-title><source>Prog Neurobiol</source><year>2001</year><volume>63</volume><fpage>71</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">11040419</pub-id></citation></ref><ref id="R44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Belluardo</surname><given-names>N</given-names></name><name><surname>Metsis</surname><given-names>M</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><article-title>Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>1280</fpage><lpage>1296</lpage><pub-id pub-id-type="pmid">9454838</pub-id></citation></ref><ref id="R45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parain</surname><given-names>K</given-names></name><name><surname>Murer</surname><given-names>MG</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Faucheux</surname><given-names>B</given-names></name><name><surname>Agid</surname><given-names>Y</given-names></name><name><surname>Hirsch</surname><given-names>E</given-names></name><name><surname>Raisman-Vozari</surname><given-names>R</given-names></name></person-group><article-title>Reduced expression of brain-derived neurotrophic factor protein in Parkinson&#x02019;s disease substantia nigra</article-title><source>Neuroreport</source><year>1999</year><volume>10</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">10208589</pub-id></citation></ref><ref id="R46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>HS</given-names></name><name><surname>Hains</surname><given-names>JM</given-names></name><name><surname>Armanini</surname><given-names>M</given-names></name><name><surname>Laramee</surname><given-names>GR</given-names></name><name><surname>Johnson</surname><given-names>SA</given-names></name><name><surname>Winslow</surname><given-names>JW</given-names></name></person-group><article-title>BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer&#x02019;s disease</article-title><source>Neuron</source><year>1991</year><volume>7</volume><fpage>695</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">1742020</pub-id></citation></ref><ref id="R47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo-Neustadt</surname><given-names>AA</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name></person-group><article-title>Brain-derived neurotrophic factor and antidepressant activity</article-title><source>Curr Pharm Des</source><year>2005</year><volume>11</volume><fpage>1495</fpage><lpage>1510</lpage><pub-id pub-id-type="pmid">15892658</pub-id></citation></ref><ref id="R48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sathanoori</surname><given-names>M</given-names></name><name><surname>Dias</surname><given-names>BG</given-names></name><name><surname>Nair</surname><given-names>AR</given-names></name><name><surname>Banerjee</surname><given-names>SB</given-names></name><name><surname>Tole</surname><given-names>S</given-names></name><name><surname>Vaidya</surname><given-names>VA</given-names></name></person-group><article-title>Differential regulation of multiple brain-derived neurotrophic factor transcripts in the postnatal and adult rat hippocampus during development, and in response to kainate administration</article-title><source>Brain Res Mol Brain Res</source><year>2004</year><volume>130</volume><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">15519687</pub-id></citation></ref><ref id="R49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schoenherr</surname><given-names>CJ</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><article-title>The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>1360</fpage><lpage>1363</lpage><pub-id pub-id-type="pmid">7871435</pub-id></citation></ref><ref id="R50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shieh</surname><given-names>PB</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name></person-group><article-title>Molecular mechanisms underlying activity-dependent regulation of BDNF expression</article-title><source>J Neurobiol</source><year>1999</year><volume>41</volume><fpage>127</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">10504200</pub-id></citation></ref><ref id="R51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shieh</surname><given-names>PB</given-names></name><name><surname>Hu</surname><given-names>SC</given-names></name><name><surname>Bobb</surname><given-names>K</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name></person-group><article-title>Identification of a signaling pathway involved in calcium regulation of BDNF expression</article-title><source>Neuron</source><year>1998</year><volume>20</volume><fpage>727</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">9581764</pub-id></citation></ref><ref id="R52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>A</given-names></name><name><surname>Sakaya</surname><given-names>H</given-names></name><name><surname>Kisukeda</surname><given-names>T</given-names></name><name><surname>Fushiki</surname><given-names>H</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name></person-group><article-title>Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>35920</fpage><lpage>35931</lpage><pub-id pub-id-type="pmid">12114522</pub-id></citation></ref><ref id="R53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Finkbeiner</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>DB</given-names></name><name><surname>Shaywitz</surname><given-names>AJ</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism</article-title><source>Neuron</source><year>1998</year><volume>20</volume><fpage>709</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">9581763</pub-id></citation></ref><ref id="R54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Chen</surname><given-names>WG</given-names></name><name><surname>Corfas</surname><given-names>G</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF</article-title><source>Neuron</source><year>2002</year><volume>33</volume><fpage>383</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">11832226</pub-id></citation></ref><ref id="R55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>HK</given-names></name><name><surname>Teng</surname><given-names>KK</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Wright</surname><given-names>S</given-names></name><name><surname>Tevar</surname><given-names>S</given-names></name><name><surname>Almeida</surname><given-names>RD</given-names></name><name><surname>Kermani</surname><given-names>P</given-names></name><name><surname>Torkin</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>ZY</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name><etal/></person-group><article-title>ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin</article-title><source>J Neurosci</source><year>2005</year><volume>25</volume><fpage>5455</fpage><lpage>5463</lpage><pub-id pub-id-type="pmid">15930396</pub-id></citation></ref><ref id="R56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>KK</given-names></name><name><surname>Hempstead</surname><given-names>BL</given-names></name></person-group><article-title>Neurotrophins and their receptors: signaling trios in complex biological systems</article-title><source>Cell Mol Life Sci</source><year>2004</year><volume>61</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">14704852</pub-id></citation></ref><ref id="R57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmusk</surname><given-names>T</given-names></name><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Metsis</surname><given-names>M</given-names></name><name><surname>Reintam</surname><given-names>T</given-names></name><name><surname>Paalme</surname><given-names>V</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name><name><surname>Persson</surname><given-names>H</given-names></name></person-group><article-title>Multiple promoters direct tissue-specific expression of the rat BDNF gene</article-title><source>Neuron</source><year>1993</year><volume>10</volume><fpage>475</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">8461137</pub-id></citation></ref><ref id="R58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmusk</surname><given-names>T</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name><name><surname>Funakoshi</surname><given-names>H</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Persson</surname><given-names>H</given-names></name><name><surname>Metsis</surname><given-names>M</given-names></name></person-group><article-title>Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice</article-title><source>J Cell Biol</source><year>1995</year><volume>128</volume><fpage>185</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">7822414</pub-id></citation></ref><ref id="R59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmusk</surname><given-names>T</given-names></name><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name><name><surname>Metsis</surname><given-names>M</given-names></name></person-group><article-title>Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>1078</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">9873054</pub-id></citation></ref><ref id="R60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsankova</surname><given-names>NM</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Renthal</surname><given-names>W</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action</article-title><source>Nat Neurosci</source><year>2006</year><volume>9</volume><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">16501568</pub-id></citation></ref><ref id="R61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsankova</surname><given-names>NM</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>5603</fpage><lpage>5610</lpage><pub-id pub-id-type="pmid">15201333</pub-id></citation></ref><ref id="R62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyler</surname><given-names>WJ</given-names></name><name><surname>Alonso</surname><given-names>M</given-names></name><name><surname>Bramham</surname><given-names>CR</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L</given-names></name></person-group><article-title>From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning</article-title><source>Learn Mem</source><year>2002</year><volume>9</volume><fpage>224</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">12359832</pub-id></citation></ref><ref id="R63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Chen</surname><given-names>WG</given-names></name><name><surname>Dalva</surname><given-names>MB</given-names></name><name><surname>Dolmetsch</surname><given-names>RE</given-names></name><name><surname>Kornhauser</surname><given-names>JM</given-names></name><name><surname>Shaywitz</surname><given-names>AJ</given-names></name><name><surname>Takasu</surname><given-names>MA</given-names></name><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Calcium regulation of neuronal gene expression</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>11024</fpage><lpage>11031</lpage><pub-id pub-id-type="pmid">11572963</pub-id></citation></ref><ref id="R64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>NH</given-names></name><name><surname>Teng</surname><given-names>HK</given-names></name><name><surname>Siao</surname><given-names>CJ</given-names></name><name><surname>Chiaruttini</surname><given-names>C</given-names></name><name><surname>Pang</surname><given-names>PT</given-names></name><name><surname>Milner</surname><given-names>TA</given-names></name><name><surname>Hempstead</surname><given-names>BL</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name></person-group><article-title>Activation of p75NTR by proBDNF facilitates hippocampal long-term depression</article-title><source>Nat Neurosci</source><year>2005</year><volume>8</volume><fpage>1069</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">16025106</pub-id></citation></ref><ref id="R65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>IC</given-names></name><name><surname>Belyaev</surname><given-names>ND</given-names></name><name><surname>Bruce</surname><given-names>AW</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Mistry</surname><given-names>M</given-names></name><name><surname>Roopra</surname><given-names>A</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><article-title>Interaction of the repressor element 1-silencing transcription factor (REST) with target genes</article-title><source>J Mol Biol</source><year>2003</year><volume>334</volume><fpage>863</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">14643653</pub-id></citation></ref><ref id="R66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Mizuno</surname><given-names>M</given-names></name><name><surname>Nabeshima</surname><given-names>T</given-names></name></person-group><article-title>Role for brain-derived neurotrophic factor in learning and memory</article-title><source>Life Sci</source><year>2002</year><volume>70</volume><fpage>735</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">11833737</pub-id></citation></ref><ref id="R67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Rosenfeld</surname><given-names>RD</given-names></name><name><surname>Matheson</surname><given-names>CR</given-names></name><name><surname>Hawkins</surname><given-names>N</given-names></name><name><surname>Lopez</surname><given-names>OT</given-names></name><name><surname>Bennett</surname><given-names>L</given-names></name><name><surname>Welcher</surname><given-names>AA</given-names></name></person-group><article-title>Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system</article-title><source>Neuroscience</source><year>1997</year><volume>78</volume><fpage>431</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">9145800</pub-id></citation></ref><ref id="R68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zafra</surname><given-names>F</given-names></name><name><surname>Castren</surname><given-names>E</given-names></name><name><surname>Thoenen</surname><given-names>H</given-names></name><name><surname>Lindholm</surname><given-names>D</given-names></name></person-group><article-title>Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons</article-title><source>Proc Natl Acad Sci U S A</source><year>1991</year><volume>88</volume><fpage>10037</fpage><lpage>10041</lpage><pub-id pub-id-type="pmid">1658793</pub-id></citation></ref><ref id="R69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zafra</surname><given-names>F</given-names></name><name><surname>Hengerer</surname><given-names>B</given-names></name><name><surname>Leibrock</surname><given-names>J</given-names></name><name><surname>Thoenen</surname><given-names>H</given-names></name><name><surname>Lindholm</surname><given-names>D</given-names></name></person-group><article-title>Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors</article-title><source>EMBO J</source><year>1990</year><volume>9</volume><fpage>3545</fpage><lpage>3550</lpage><pub-id pub-id-type="pmid">2170117</pub-id></citation></ref><ref id="R70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccato</surname><given-names>C</given-names></name><name><surname>Ciammola</surname><given-names>A</given-names></name><name><surname>Rigamonti</surname><given-names>D</given-names></name><name><surname>Leavitt</surname><given-names>BR</given-names></name><name><surname>Goffredo</surname><given-names>D</given-names></name><name><surname>Conti</surname><given-names>L</given-names></name><name><surname>MacDonald</surname><given-names>ME</given-names></name><name><surname>Friedlander</surname><given-names>RM</given-names></name><name><surname>Silani</surname><given-names>V</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Loss of huntingtin-mediated BDNF gene transcription in Huntington&#x02019;s disease</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>493</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">11408619</pub-id></citation></ref><ref id="R71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccato</surname><given-names>C</given-names></name><name><surname>Tartari</surname><given-names>M</given-names></name><name><surname>Crotti</surname><given-names>A</given-names></name><name><surname>Goffredo</surname><given-names>D</given-names></name><name><surname>Valenza</surname><given-names>M</given-names></name><name><surname>Conti</surname><given-names>L</given-names></name><name><surname>Cataudella</surname><given-names>T</given-names></name><name><surname>Leavitt</surname><given-names>BR</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name><etal/></person-group><article-title>Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes</article-title><source>Nat Genet</source><year>2003</year><volume>35</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">12881722</pub-id></citation></ref></ref-list><sec id="S16" sec-type="display-objects"><title>Figures</title><fig id="F1" position="float"><label>Fig. 1</label><caption><p><bold>Exon/intron structure and alternative transcripts of mouse and rat BDNF genes.</bold> (A) Rat BDNF gene structure as described by <xref ref-type="bibr" rid="R57">Timmusk et al., 1993</xref>. Exons are shown as boxes and introns are shown as lines. (B) The new arrangement of exons and introns of mouse and rat BDNF genes as determined by analyzing genomic and mRNA sequence data using bioinformatics, 5&#x02019; RACE and RT-PCR. The schematic representation of BDNF transcripts in relation to the gene is shown below the gene structure. Protein coding regions are shown as filled boxes and untranslated regions are shown as white boxes. Each of the eight 5&#x02032; untranslated exons is spliced to the common 3&#x02032; protein coding exon IX. In addition, transcription can be initiated in the intron before the protein coding exon, which results in IXA transcripts containing 5&#x02032;-extended coding exon. Each transcription unit may use one of the two alternative polyadenylation signals in the 3&#x02032; exon (indicated by arrows). For exon II, three different transcript variants IIA, IIB and IIC are generated as a result of using alternative splice-donor sites in exon II (arrows A, B and C).</p></caption><graphic xlink:href="nihms-543-f0001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p><bold>Expression analysis of mouse and rat BDNF mRNAs.</bold> Semiquantitive RT-PCR analysis of tissue-specific expression of mouse (A) and rat (B) BDNF transcripts and control HPRT mRNA was performed in developing and adult brain and in peripheral organs. Abbreviations: E, embryonic day; P, postnatal day.</p></caption><graphic xlink:href="nihms-543-f0002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><p><bold>Identification of the transcription start sites for BDNF new exon III, V, VII, VIII and IXA mRNAs in rat.</bold> 5&#x02019; Rapid amplification of cDNA ends (5&#x02019;RACE) was performed to determine the transcription start sites for novel BDNF transcripts. Major transcription initiation sites (small arrows) are located at 152 bp and 230 bp for exon III (arrows A and B), at 81 bp for exon V and at 277 bp and 286 bp for exon VIII (arrows A and B) upstream of the 3&#x02019; end of the respective exon and at 476 bp and 363 bp upstream of the major splice acceptor site of the coding exon (shown by an asterisk) for exon IXA. For exon VII the 5&#x02032; end of the longest EST is shown as a putative transcription initiation site, because 5&#x02019; RACE did not result in any specific products due to very low levels of exon VII transcripts. Exon sequences are in bold, intron sequences are in lower-case letters. The locations of primers that were used in 5&#x02019; RACE are indicated with long arrows.</p></caption><graphic xlink:href="nihms-543-f0003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><p><bold>Differential regulation of BDNF gene expression by DNA methylation and histone deacetylation.</bold> The role of DNA methylation on transcriptional activity of BDNF promoters was investigated by treating rat C6 glioma and mouse Neuro2A neuroblastoma cells with 1 &#x003bc;M 5-Aza-deoxycytidine (5AzadC) for 48 hours. The effects of inhibition of histone deacetylation was studied by treating Neuro2A and C6 cells with 300 nM trichostatin A (TSA) for 48 hours. Muscarinic acetylcholine receptor M4 gene and constitutive hypoxanthine-phosphoribosyltransferase (HPRT) gene were used as reference genes.</p></caption><graphic xlink:href="nihms-543-f0004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><p><bold>Activity-dependent regulation of BDNF exon-specific mRNAs in rat hippocampus by kainic acid-induced seizures.</bold> The effect of kainate-induced seizures on the expression of different BDNF transcripts in the hippocampus of adult rat brain was examined. Adult rats were injected subcutaneously with kainic acid (8 mg per kg body weight) and sacrificed 1, 3, 6, 12 and 24 hours post-treatment. Total RNA was extracted and semiquantitative RT-PCR was performed. Untreated rat hippocampus RNA was used as a control.</p></caption><graphic xlink:href="nihms-543-f0005"/></fig></sec></back></article> 